标题
RNA Therapeutics - Research and Clinical Advancements
作者
关键词
-
出版物
Frontiers in Molecular Biosciences
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-09-22
DOI
10.3389/fmolb.2021.710738
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
- (2020) Huilin Huang et al. CANCER CELL
- The emerging role of RNA modifications in the regulation of mRNA stability
- (2020) Sung Ho Boo et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- A phase II study of siG12D-LODER in combination with chemotherapy in patients with locally advanced pancreatic cancer (PROTACT).
- (2020) Anna M. Varghese et al. JOURNAL OF CLINICAL ONCOLOGY
- Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
- (2020) Frederick J. Raal et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19, Virology and Geroscience: A Perspective
- (2020) Camille Vellas et al. Journal of Nutrition Health & Aging
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
- (2020) Ugur Sahin et al. NATURE
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
- (2020) Kizzmekia S. Corbett et al. NEW ENGLAND JOURNAL OF MEDICINE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of MicroRNAs in Bone Metabolism and Disease
- (2020) Yongguang Gao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration
- (2020) Glenn J. Jaffe et al. OPHTHALMOLOGY
- Synthetic mRNA Encoding VEGF-A in Patients Undergoing Coronary Artery Bypass Grafting: Design of a Phase 2a Clinical Trial
- (2020) Vesa Anttila et al. Molecular Therapy-Methods & Clinical Development
- An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM‐080301 in Subjects with Advanced Hepatocellular Carcinoma
- (2019) Imane El Dika et al. ONCOLOGIST
- Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes
- (2019) Li-Ming Gan et al. Nature Communications
- Chemical methods for the modification of RNA
- (2019) Marie Flamme et al. METHODS
- Mirror‐Image Oligonucleotides: History and Emerging Applications
- (2019) Brian E. Young et al. CHEMISTRY-A EUROPEAN JOURNAL
- A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors.
- (2019) Howard A. Burris et al. JOURNAL OF CLINICAL ONCOLOGY
- Lipid Nanoparticles for Delivery of Therapeutic RNA Oligonucleotides
- (2019) Keith Henry Moss et al. MOLECULAR PHARMACEUTICS
- siRNA therapeutics: a clinical reality
- (2019) Phei Er Saw et al. Science China-Life Sciences
- mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
- (2019) Robert A. Feldman et al. VACCINE
- Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration.
- (2019) David S. Liao et al. OPHTHALMOLOGY
- RNA Interference Therapy with ARC‐520 Results in Prolonged HBsAg Response in Patients with Chronic Hepatitis B Infection
- (2019) Man‐Fung Yuen et al. HEPATOLOGY
- The Development of Functional Non-Viral Vectors for Gene Delivery
- (2019) Patil et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- N6-Methyladenosine Modification Controls Circular RNA Immunity
- (2019) Y. Grace Chen et al. MOLECULAR CELL
- Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application
- (2019) Adachi et al. MOLECULES
- Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities
- (2018) Ling Li et al. BIOMATERIALS
- Noncoding RNAs in disease
- (2018) Evangelia Lekka et al. FEBS LETTERS
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Maximizing the translational yield of mRNA therapeutics by minimizing 5'-UTRs
- (2018) Zeljka Trepotec et al. TISSUE ENGINEERING PART A
- Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine
- (2018) Leif Carlsson et al. Molecular Therapy-Methods & Clinical Development
- RNA therapeutics for heart disease
- (2018) Federica De Majo et al. BIOCHEMICAL PHARMACOLOGY
- Abstract CT156: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma
- (2018) Robert A. Jabulowsky et al. CANCER RESEARCH
- Patisiran: First Global Approval
- (2018) Sheridan M. Hoy DRUGS
- Age-related macular degeneration
- (2018) Paul Mitchell et al. LANCET
- Polo-like kinases and acute leukemia
- (2018) Oksana Goroshchuk et al. ONCOGENE
- La maladie de Willebrand
- (2018) L. Calmette et al. REVUE DE MEDECINE INTERNE
- Modified PAMAM vehicles for effective TRAIL gene delivery to colon adenocarcinoma: in vitro and in vivo evaluation
- (2018) Elham Pishavar et al. Artificial Cells Nanomedicine and Biotechnology
- Splice-Modulating Oligonucleotide QR-110 Restores CEP290 mRNA and Function in Human c.2991+1655A>G LCA10 Models
- (2018) Kalyan Dulla et al. Molecular Therapy-Nucleic Acids
- Phase I trial of intravenous Ad5CRT in patients with liver metastasis of gastrointestinal cancers
- (2018) Sang-Jin Lee et al. CANCER GENE THERAPY
- Polyethylenimine-based formulations for delivery of oligonucleotides
- (2018) Fei Hao et al. CURRENT MEDICINAL CHEMISTRY
- Modified gelatin nanoparticles for gene delivery
- (2018) Osama Madkhali et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases
- (2018) Zeljka Trepotec et al. MOLECULAR THERAPY
- A bone-resorption surface-targeting nanoparticle to deliver anti-miR214 for osteoporosis therapy
- (2017) Mingxiang Cai et al. International Journal of Nanomedicine
- Cytomegalovirus Retinitis: A Review
- (2017) Alexander D. Port et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
- (2017) Martin Alberer et al. LANCET
- Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA)
- (2017) Michael J. Wagner et al. MOLECULAR CANCER THERAPEUTICS
- Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
- (2017) Norbert Pardi et al. NATURE
- Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
- (2017) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration
- (2017) Glenn J. Jaffe et al. OPHTHALMOLOGY
- Therapeutic effects of protein kinase N3 small interfering RNA and doxorubicin combination therapy on liver and lung metastases
- (2017) Yoshiyuki Hattori et al. Oncology Letters
- Advances in the delivery of RNA therapeutics: from concept to clinical reality
- (2017) James C. Kaczmarek et al. Genome Medicine
- Treatment with QPI-1002, a Short Interfering (SI) RNA for the Prophylaxis of Delayed Graft Function.
- (2017) V. Peddi et al. TRANSPLANTATION
- Osteoblast-Targeting-Peptide Modified Nanoparticle for siRNA/microRNA Delivery
- (2016) Yao Sun et al. ACS Nano
- Spell Checking Nature: Versatility of CRISPR/Cas9 for Developing Treatments for Inherited Disorders
- (2016) Daria Wojtal et al. AMERICAN JOURNAL OF HUMAN GENETICS
- What is CRISPR/Cas9?
- (2016) Melody Redman et al. Archives of Disease in Childhood-Education and Practice Edition
- A phase Ib/IIa study of combination therapy with gemcitabine and Atu027 in patients with locally advanced or metastatic pancreatic adenocarcinoma.
- (2016) Beate Schultheis et al. JOURNAL OF CLINICAL ONCOLOGY
- siRNA Therapeutics for Primary Hyperoxaluria: A Beginning
- (2016) Dawn S Milliner MOLECULAR THERAPY
- Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1
- (2016) Chaitali Dutta et al. MOLECULAR THERAPY
- C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria
- (2016) Jan Menne et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration
- (2016) Glenn J. Jaffe et al. OPHTHALMOLOGY
- From the RNA world to the clinic
- (2016) B. A. Sullenger et al. SCIENCE
- A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclasts
- (2015) Jin Liu et al. BIOMATERIALS
- Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer® therapeutics
- (2015) Axel Vater et al. DRUG DISCOVERY TODAY
- RNA-targeted Therapeutics for ALS
- (2015) Linga V. Reddy et al. Neurotherapeutics
- Age-Related Macular Degeneration
- (2015) Sonia Mehta PRIMARY CARE
- In vivo gene editing in dystrophic mouse muscle and muscle stem cells
- (2015) M. Tabebordbar et al. SCIENCE
- Crystal structure of a mirror-image L-RNA aptamer (Spiegelmer) in complex with the natural L-protein target CCL2
- (2015) Dominik Oberthür et al. Nature Communications
- RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients
- (2015) Talia Golan et al. Oncotarget
- Abstract 3847: The anti-hepcidin Spiegelmer® Lexaptepid Pegol (NOX-H94) as treatment of anemia of chronic disease in patients with multiple myeloma, low grade lymphoma, and CLL: A phase II pilot study
- (2015) Pencho Georgiev et al. CANCER RESEARCH
- mRNA transcript therapy
- (2014) Drew Weissman Expert Review of Vaccines
- Genome modification by CRISPR/Cas9
- (2014) Yuanwu Ma et al. FEBS Journal
- Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 andpiggyBac
- (2014) Fei Xie et al. GENOME RESEARCH
- First-in-Human Phase I Study of the Liposomal RNA Interference Therapeutic Atu027 in Patients With Advanced Solid Tumors
- (2014) Beate Schultheis et al. JOURNAL OF CLINICAL ONCOLOGY
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection
- (2014) W. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- Toxicological and Pharmacokinetic Properties of QPI-1007, a Chemically Modified Synthetic siRNA Targeting Caspase 2 mRNA, Following Intravitreal Injection
- (2014) Elisabeth C.R. Solano et al. Nucleic Acid Therapeutics
- Noncoding RNAs in DNA Repair and Genome Integrity
- (2013) Guohui Wan et al. ANTIOXIDANTS & REDOX SIGNALING
- Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients
- (2013) Gerald Schwank et al. Cell Stem Cell
- Aptamers: multifunctional molecules for biomedical research
- (2013) Jayeeta Banerjee et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- An open-label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer
- (2012) Phuong Khanh Morrow et al. CANCER
- Evaluation of the siRNA PF-04523655 versus Ranibizumab for the Treatment of Neovascular Age-related Macular Degeneration (MONET Study)
- (2012) Quan Dong Nguyen et al. OPHTHALMOLOGY
- Synthesis of 2′-O-guanidinopropyl-modified nucleoside phosphoramidites and their incorporation into siRNAs targeting hepatitis B virus
- (2011) Jolanta Brzezinska et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
- (2011) Katalin Karikó et al. NUCLEIC ACIDS RESEARCH
- The von Willebrand Inhibitor ARC1779 Reduces Cerebral Embolization After Carotid Endarterectomy
- (2011) Hugh S. Markus et al. STROKE
- RNAi-Based Treatment for Neovascular Age-Related Macular Degeneration by Sirna-027
- (2010) Peter K. Kaiser et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro
- (2010) Teppei Morikawa et al. HUMAN PATHOLOGY
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- (2010) Mark E. Davis et al. NATURE
- The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo
- (2010) Florian B. Mayr et al. TRANSFUSION
- First-in-human Mutation-targeted siRNA Phase Ib Trial of an Inherited Skin Disorder
- (2009) Sancy A Leachman et al. MOLECULAR THERAPY
- Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells
- (2009) Ronald T Mitsuyasu et al. NATURE MEDICINE
- Leber congenital amaurosis: Genes, proteins and disease mechanisms
- (2008) Anneke I. den Hollander et al. PROGRESS IN RETINAL AND EYE RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started